Latest Analgesics Stories
RALEIGH, N.C., Oct. 10, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that J.
The Firm is evaluating Tylenol lawsuits on behalf of individuals who suffered serious liver damage, allegedly due to the acetaminophen in over-the-counter Tylenol products. New
New white paper released as hydrocodone is reclassified as a Schedule II drug ITASCA, Ill., Oct.
The Firm is actively evaluating Tylenol lawsuits on behalf of individuals who sustained sudden liver failure that required hospitalization, the need for a transplant, and/or resulted in death
Always "Double Check; Don't Double Up" When Treating Symptoms WASHINGTON, Sept.
KemPharm Joins CLADD in Support of Legislation from Health Canada to Encourage More Responsible Development and Administration of Prescription Opioids CORALVILLE, Iowa, Sept.
WHIPPANY, N.J., Sept.
Studies to Investigate Ability of KP201 to Deter Abuse and Reduce Opioid-Induced Constipation CORALVILLE, Iowa, Sept.
- The parings of haberdine; also, any kind of fragments.